JSE-listed Aspen Pharmacare will adjust production schedules at its manufacturing plants to ensure supplies of critical medicines, such as antibiotics, should SA’s Covid-19 outbreak trigger a sudden increase in demand, according to CEO Stephen Saad.

There is no vaccine or cure for the coronavirus that causes Covid-19, but there could well be a surge in demand for products such as antibiotics to treat secondary infections, he said. Aspen has also given the government an undertaking that it will alter its production plans to ensure continued supplies of other critical drugs, including those used for chronic conditions, should the need arise, he said...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.

Already subscribed? Simply sign in below.



Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now